Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 15, 2013

View Archived Issues

Bivalent norovirus vaccine protects against illness in oral challenge study

Varicella zoster vaccine candidate is immunogenic in patients with HIV infection

CD151 antigen expression correlated with progression in advanced gastric cancer

Bioengineering of a novel nanotechnology-based drug delivery system

Rational computational design of high-affinity, small-molecule-selective binding proteins

Anxiolytic activity demonstrated for RU-476

Mesoblast acquires Osiris' culture-expanded mesenchymal stem cell business

Novel photoimmunoconjugates discovered by German group

Researchers disclose new monoclonal antibodies for cancer and ocular disorders

Takeda Pharmaceutical prepares novel GL-R antagonists for diabetes

CCI Corporation patents new agents for cancer

New Aurora kinase inhibitors synthesized at Sunshine Lake Pharma

Clavis Pharma becomes Aqualis

Alcobra presents new findings on MG-01CI

Protalix BioTherapeutics reports phase I data for PRX-112

MannKind resubmits Afrezza NDA

Topline data from phase II TRUST-I trial in Crohn's disease reported

FDA releases drug safety communication for ponatinib

Otrexup injection approved by the FDA for several indications

Cellceutix plans to begin phase IIb trial of Brilacidin in 2014

Boehringer Ingelheim and Lilly submit application in Japan for empagliflozin

Acacia Pharma's phase II trial of APD-515 for xerostomia meets primary endpoint

Immatics raises funds to complete development of IMA-901 for renal cancer

Janssen files MAA with EMA for fixed-dose combination of darunavir and cobicistat

MedImmune acquires biotech company and invests in ADC Therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...